If 50 units produces good results and tolerable side effects, there is no clinical reason to continue escalating
Liraglutide is generally cheaper than semaglutide
Ozempic is safe and effective when used as indicated for the treatment of adults with type 2 diabetes to lower blood sugar, along with diet and exercise, reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who also have heart disease, and lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease

Other medications in this class include: Wegovy (semaglutide) - Same active ingredient as Ozempic, but FDA-approved for weight loss Mounjaro/Zepbound (tirzepatide) - Dual-action medication approved for diabetes (Mounjaro) and weight loss (Zepbound) Trulicity (dulaglutide) - Weekly injection for type 2 diabetes Victoza/Saxenda (liraglutide) - Available for diabetes (Victoza) and weight loss (Saxenda) Bydureon (exenatide) - Weekly injection, older medication in this class All of these work similarly by mimicking natural hormones that control blood sugar and appetite, though they may have different dosing schedules and approved uses.
These effects are not necessarily direct results of semaglutides action, but rather secondary effects due to changes in blood sugar control, hydration, or appetite
Important safety note: The FDA advises against using quinine or quinine-containing products (including tonic water) for leg cramps due to serious safety concerns